DRACHMAN JONATHAN G

CIK 00015884674 companiesBOTHELL, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001588467

Recent Transactions

50 trades

Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−1,016→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−5,415→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−5,531→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,300→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-03-08+415→ 5,415 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-27+5,000→ 5,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2023-06-22+23,000→ 23,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2022-08-02+350,000→ 350,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 total
Purchase
Calithera Biosciences, Inc.
Common Stock
2021-11-10$0.86/sh+200,000→ 200,000 total
Gift
Neurogene Inc.$NGNE
Common Stock
2021-10-26+75,000→ 100,000 total
Gift
Neurogene Inc.$NGNE
Common Stock
2021-10-26−75,000→ 2,198,686 total
Gift
Neurogene Inc.$NGNE
Common Stock
2021-10-26−75,000→ 2,198,686 total
Gift
Neurogene Inc.$NGNE
Common Stock
2021-10-26+75,000→ 100,000 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2021-08-25$6.45/sh+25,000→ 25,000 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2021-08-25$6.45/sh+25,000→ 25,000 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2021-08-24$6.11/sh+100,000→ 2,348,686 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2021-08-03+400,000→ 400,000 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2021-06-11+20,000→ 20,000 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2021-06-04$9.61/sh+10,000→ 2,248,686 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2021-06-03$9.48/sh+40,000→ 2,238,686 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2020-08-10+420,000→ 420,000 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2020-06-09+20,000→ 20,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2020-05-28+2,880→ 2,880 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2020-05-28+10,167→ 10,167 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2019-12-20$8.40/sh+119,047→ 2,198,686 total
Conversion
Neurogene Inc.$NGNE
Common Stock
2019-11-12+1,261,600→ 2,079,639 total
Conversion
Neurogene Inc.$NGNE
Series A Preferred Stock
2019-11-12−12,616→ 0 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2019-09-11$3.30/sh+136,436→ 584,428 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2019-09-10$3.08/sh+36,742→ 447,992 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2019-09-09$2.85/sh+76,822→ 411,250 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2019-08-31+1,650,000→ 1,650,000 total
Award
Neurogene Inc.$NGNE
Series A Preferred Stock
2019-08-08+12,616→ 12,616 total
Award
Neurogene Inc.$NGNE
Series A Preferred Stock
2019-08-08+7,428→ 7,428 total
Award
Neurogene Inc.$NGNE
Common Stock
2019-08-08+334,428→ 334,428 total
Award
Neurogene Inc.$NGNE
Common Stock
2019-08-08+568,039→ 568,039 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2019-06-03+10,167→ 10,167 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2019-05-30+11,000→ 11,000 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2019-02-07+4,266→ 4,266 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2018-05-31+11,000→ 11,000 total
Exercise/Conversion
Seagen Inc.
Common Stock
2018-03-20$26.10/sh+3,831→ 174,765 total
Exercise/Conversion
Seagen Inc.
Common Stock
2018-03-20$10.61/sh+7,000→ 201,973 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2018-03-20−7,000→ 0 total
Exercise/Conversion
Seagen Inc.
Incentive Stock Option (right to buy)
2018-03-20−6,468→ 0 total
Exercise/Conversion
Seagen Inc.
Common Stock
2018-03-20$15.46/sh+6,468→ 181,233 total
Exercise/Conversion
Seagen Inc.
Incentive Stock Option (right to buy)
2018-03-20−3,831→ 0 total
Exercise/Conversion
Seagen Inc.
Common Stock
2018-03-20$12.00/sh+13,740→ 194,973 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2018-03-20−13,740→ 45,000 total

Companies

Recent Filings

Address

21823 30TH DRIVE SE

BOTHELL, WA, 98021

View on SEC.gov